Previously, it has been shown that specific NKX2-5 mutations result in abnormal protein degradation through the Ubiquitin-Proteasome system and can contribute to CHD due to partially impaired transcriptional activity [34]. The gene discussed is NKX2-5; the disease is coronary artery disorder.